Results 101 to 110 of about 443,505 (210)
Objectives To describe changes in respiratory syncytial virus (RSV) epidemiology, its associated clinical outcomes and predictors of severe acute lower respiratory tract infection (ALRTI) pre- and post-COVID-19.
Enas Al-Zayadneh +8 more
doaj +1 more source
Introduction Respiratory syncytial virus (RSV) is a public health concern, particularly among neonates/young infants, in individuals with chronic medical conditions, and for older adults.
Yu-Jiun Chan +14 more
doaj +1 more source
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants and young children. The COVID-19 pandemic significantly disrupted global RSV epidemiology. This study aimed to investigate the impact of the pandemic on
Shan-Yin Pai +7 more
doaj +1 more source
Introduction: Respiratory syncytial virus (RSV) is the main etiological agent in pediatric lower respiratory tract infections. The limited availability of therapeutic options for severe clinical cases associated with RSV infection makes prophylactic ...
Paolo Solidoro +11 more
doaj +1 more source
Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy
Background Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause of infant death after malaria.
Melania Dovizio +15 more
doaj +1 more source
The epidemiology of respiratory syncytial virus (RSV) infections in South African children.
To review the incidence, outcomes and risk factors associated with respiratory syncytial virus (RSV) infection in South African children.Review of published literature and laboratory records.Review of the published literature. Articles listed on MEDLINE with 'South African' or 'children' and 'respiratory syncytial virus' or 'acute respiratory tract ...
Vardas, Eftyhia +2 more
openaire +2 more sources
BACKGROUND AND AIMS: Respiratory syncytial virus (RSV) infection is one of the leading causes of hospitalisation in infants, the elderly and immunocompromised patients, with significant morbidity and mortality rates.
Alexander Kuznetsov +6 more
doaj +1 more source
Respiratory syncytial virus (RSV) is a leading cause of respiratory illness among infants. A maternal RSV vaccine that protects young infants has recently been approved for registration in Australia. We estimated the population benefits of a future year-round maternal RSV vaccination program in terms of prevented RSV infections and hospitalisations in ...
Allen L, Nazareno +4 more
openaire +2 more sources
Background Data on economic costs of respiratory syncytial virus (RSV) infections among children in primary care are scarce, although most RSV-infections are managed in this setting. Aim To estimate outpatient costs for RSV-positive children aged
Jojanneke van Summeren +16 more
core +1 more source
Background: Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory infections in children under 5 years, but data on its epidemiology in this region are limited.
Bashir Ahmad Fomda +4 more
doaj +1 more source

